Carnegie Mellon University
In its 13F for Q3 2024 (holdings as of September 30, 2024, filed November 13, 2024), Carnegie Mellon University reported 4 stock positions worth $96.9 million. Its top holding was Duolingo (DUOL) at 99.9% of the portfolio, followed by Longevity Health (0.1%) and Innsuites Hospitality Trust (IHT, 0.0%). Compared with Q2 2024, it added to 1 and reduced 1. The biggest buy was Longevity Health (shares +30%) and the biggest sale Duolingo (DUOL, shares −3%).
- Most Recent 13F
- Q2 2026
- Location
- Pittsburgh, PA
- CIK
- 0001039067
- Portfolio Value
- $96.9M (Q3 2024)
- SEC Filing
- 0000898432-24-000914 ↗ filed Nov 13, 2024
Holdings Value
Holdings 4 stocks · $96.9M
| DUOL Duolingo | 99.92% | 343,314 | $96.8M | Reduce -2.8% |
| LONGEVITY HEALTH HLDGS INC filed as CARMELL CORPORATION | 0.06% | 134,469 | $54K | Add +30.5% |
| IHT Innsuites Hospitality Trust | 0.02% | 10,000 | $18K | No change |
| PREDICTIVE ONCOLOGY INC | 0.01% | 10,358 | $8K | No change |
Portfolio Sells Q2 2024 → Q3 2024
| DUOL Duolingo | Reduce -2.8% | 99.92% | +0.14 |
Portfolio Buys Q2 2024 → Q3 2024
| LONGEVITY HEALTH HLDGS INC | Add +30.5% | 0.06% | −0.13 |
All Filings
| Quarter | Positions | 13F Reported Value | Top Holdings |
|---|---|---|---|
| Q2 2026 | 5 | $78.9M | QQQ, DUOL, IHT, AGPU, LONGEVITY HEALTH HLDGS INC |
| Q1 2026 | 5 | $64.3M | QQQ, DUOL, IHT, LONGEVITY HEALTH HLDGS INC, AGPU |
| Q4 2025 | 5 | $89.3M | DUOL, QQQ, IHT, AGPU, LONGEVITY HEALTH HLDGS INC |
| Q3 2025 | 5 | $131.6M | DUOL, QQQ, IHT, PREDICTIVE ONCOLOGY INC, LONGEVITY HEALTH HLDGS INC |
| Q2 2025 | 5 | $154.6M | DUOL, QQQ, IHT, LONGEVITY HEALTH HLDGS INC, PREDICTIVE ONCOLOGY INC |
| Q1 2025 | 6 | $129.0M | DUOL, QQQ, PDD, IHT, LONGEVITY HEALTH HLDGS INC |
| Q4 2024 | 6 | $136.7M | DUOL, QQQ, PDD, LONGEVITY HEALTH HLDGS INC, IHT |
| Q3 2024 | 4 | $96.9M | DUOL, LONGEVITY HEALTH HLDGS INC, IHT, PREDICTIVE ONCOLOGY INC |
| Q2 2024 | 4 | $73.9M | DUOL, LONGEVITY HEALTH HLDGS INC, IHT, PREDICTIVE ONCOLOGY INC |
| Q1 2024 | 6 | $80.1M | DUOL, VERA, LONGEVITY HEALTH HLDGS INC, PREDICTIVE ONCOLOGY INC, NBSE |